Register for email alerts and news feeds:
This journal | BMJ Group
rss
Molecular Pathology 2002;55:294-299; doi:10.1136/mp.55.5.294
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Molecular Pathology 2002;55:294-299
© 2002 Journal of Clinical Pathology

ORIGINAL ARTICLE

Further evidence to support the melanocytic origin of MDA-MB-435

G Ellison, T Klinowska, R F R Westwood, E Docter, T French and J C Fox

AstraZeneca, Mereside, Alderley Park, Macclesfield SK10 4TG, UK

Correspondence to:
Correspondence to:
Dr G Ellison, AstraZeneca, 19G22, Mereside, Alderely Park, Macclesfield SK10 4TG, UK;
gillian.ellison{at}astrazeneca.com

Background/Aims: Until recently, the cell line MDA-MB-435 was widely accepted as originating from a breast cancer. However, microarray derived data have suggested that this cell line may in fact originate from an occult melanoma. This study was designed to investigate this hypothesis further.

Methods: Quantitative reverse transcription polymerase chain reaction and immunohistochemistry were used to investigate the tissue of origin of two sublines of MDA-MB-435 (MDA-MB-435 S and MDA-MB-435 HGF). The expression of a panel of genes typical of breast cells or melanocytes was analysed.

Results: The MDA-MD-435 cell lines expressed none of the genes characteristic of breast cancer cells but did express several genes commonly expressed by melanocytes.

Conclusions: These results strongly suggest that MDA-MB-435 is indeed of melanoma origin.

Keywords: MDA-MB-435 cell line; quantitative reverse transcription polymerase chain reaction; melanoma

Abbreviations: ATCC, American Type Culture Collection; DAB, diaminobenzidine; ECACC, European Collection of Cell Cultures; EMA, epithelial membrane antigen; FCS, fetal calf serum; HGF, hepatocyte growth factor; HPRT, hypoxanthine ribosyl transferase; NEAA, non-essential amino acids; RT-PCR, reverse transcription polymerase chain reaction; SCID, severe combined immunodeficient


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Chambers, A. F. (2009). MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?. Cancer Res. 69: 5292-5293 [Abstract] [Full Text]  
  • Chen, M., Sinha, M., Luxon, B. A., Bresnick, A. R., O'Connor, K. L. (2009). Integrin {alpha}6{beta}4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin. J. Biol. Chem. 284: 1484-1494 [Abstract] [Full Text]  
  • Elliott, A. M., Al-Hajj, M. A. (2009). ABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome. Mol Cancer Res 7: 79-87 [Abstract] [Full Text]  
  • Hollingshead, M. G. (2008). Antitumor Efficacy Testing in Rodents. JNCI J Natl Cancer Inst 100: 1500-1510 [Abstract] [Full Text]  
  • Ehrich, M., Turner, J., Gibbs, P., Lipton, L., Giovanneti, M., Cantor, C., van den Boom, D. (2008). Cytosine methylation profiling of cancer cell lines. Proc. Natl. Acad. Sci. USA 105: 4844-4849 [Abstract] [Full Text]  
  • Phadke, P. A., Vaidya, K. S., Nash, K. T., Hurst, D. R., Welch, D. R. (2008). BRMS1 Suppresses Breast Cancer Experimental Metastasis to Multiple Organs by Inhibiting Several Steps of the Metastatic Process. Am. J. Pathol. 172: 809-817 [Abstract] [Full Text]  
  • Shen, F., Chu, S., Bence, A. K., Bailey, B., Xue, X., Erickson, P. A., Montrose, M. H., Beck, W. T., Erickson, L. C. (2008). Quantitation of Doxorubicin Uptake, Efflux, and Modulation of Multidrug Resistance (MDR) in MDR Human Cancer Cells. J. Pharmacol. Exp. Ther. 324: 95-102 [Abstract] [Full Text]  
  • Reinhold, W. C., Reimers, M. A., Maunakea, A. K., Kim, S., Lababidi, S., Scherf, U., Shankavaram, U. T., Ziegler, M. S., Stewart, C., Kouros-Mehr, H., Cui, H., Dolginow, D., Scudiero, D. A., Pommier, Y. G., Munroe, D. J., Feinberg, A. P., Weinstein, J. N. (2007). Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Molecular Cancer Therapeutics 6: 391-403 [Abstract] [Full Text]  
  • Jeffery, P L, Murray, R E, Yeh, A H, McNamara, J F, Duncan, R P, Francis, G D, Herington, A C, Chopin, L K (2005). Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer 12: 839-850 [Abstract] [Full Text]  
  • Hollingshead, M. G., Carter, J. P., Dougherty, K., Bonomi, C. A. (2005). The Hollow Fiber Assay in Cancer Efficacy Testing in the Developmental Therapeutics Program at the National Cancer Institute. aacredbook 2005: 351-354 [Full Text]  
  • Sandberg, R., Ernberg, I. (2005). Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc. Natl. Acad. Sci. USA 102: 2052-2057 [Abstract] [Full Text]  
  • Moroni, M., Soldatenkov, V., Zhang, L., Zhang, Y., Stoica, G., Gehan, E., Rashidi, B., Singh, B., Ozdemirli, M., Mueller, S. C. (2004). Progressive Loss of Syk and Abnormal Proliferation in Breast Cancer Cells. Cancer Res. 64: 7346-7354 [Abstract] [Full Text]  
  • Alley, M. C., Hollingshead, M. G., Pacula-Cox, C. M., Waud, W. R., Hartley, J. A., Howard, P. W., Gregson, S. J., Thurston, D. E., Sausville, E. A. (2004). SJG-136 (NSC 694501), A Novel Rationally Designed DNA Minor Groove Interstrand Cross-Linking Agent with Potent and Broad Spectrum Antitumor Activity: Part 2: Efficacy Evaluations. Cancer Res. 64: 6700-6706 [Abstract] [Full Text]  
  • Duncan, R. E., El-Sohemy, A., Archer, M. C. (2004). Mevalonate Promotes the Growth of Tumors Derived from Human Cancer Cells in Vivo and Stimulates Proliferation in Vitro with Enhanced Cyclin-dependent Kinase-2 Activity. J. Biol. Chem. 279: 33079-33084 [Abstract] [Full Text]  
  • Liang, Z., Wu, T., Lou, H., Yu, X., Taichman, R. S., Lau, S. K., Nie, S., Umbreit, J., Shim, H. (2004). Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4. Cancer Res. 64: 4302-4308 [Abstract] [Full Text]  
  • Sellappan, S., Grijalva, R., Zhou, X., Yang, W., Eli, M. B., Mills, G. B., Yu, D. (2004). Lineage Infidelity of MDA-MB-435 Cells: Expression of Melanocyte Proteins in a Breast Cancer Cell Line. Cancer Res. 64: 3479-3485 [Abstract] [Full Text]  
  • Sachdev, D., Hartell, J. S., Lee, A. V., Zhang, X., Yee, D. (2004). A Dominant Negative Type I Insulin-like Growth Factor Receptor Inhibits Metastasis of Human Cancer Cells. J. Biol. Chem. 279: 5017-5024 [Abstract] [Full Text]  
  • Huang, Y., Keen, J. C., Hager, E., Smith, R., Hacker, A., Frydman, B., Valasinas, A. L., Reddy, V. K., Marton, L. J., Casero, R. A. Jr., Davidson, N. E. (2004). Regulation of Polyamine Analogue Cytotoxicity by c-Jun in Human MDA-MB-435 Cancer Cells. Mol Cancer Res 2: 81-88 [Abstract] [Full Text]  
  • Kremer, M., Quintanilla-Martinez, L., Fuchs, M., Gamboa-Dominguez, A., Haye, S., Kalthoff, H., Rosivatz, E., Hermannstadter, C., Busch, R., Hofler, H., Luber, B. (2003). Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis. Carcinogenesis 24: 1879-1886 [Abstract] [Full Text]  
  • Huang, Y., Hager, E. R., Phillips, D. L., Dunn, V. R., Hacker, A., Frydman, B., Kink, J. A., Valasinas, A. L., Reddy, V. K., Marton, L. J., Casero, R. A. Jr., Davidson, N. E. (2003). A Novel Polyamine Analog Inhibits Growth and Induces Apoptosis in Human Breast Cancer Cells. Clin. Cancer Res. 9: 2769-2777 [Abstract] [Full Text]  

Pathology jobs

Pathology jobs